speb/financial-data huggingface dataset:
GLAXO.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 6254097000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 2220571000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -2831297000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 26200000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -134548000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Amortization: 105370000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 105370000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 265000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 169406034.00
GLAXO.NS income_statement (annual, 2024-03-31) — Basic EPS: 34.83
GLAXO.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 349409000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 1273734000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -312215000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 186650000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 1694060000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 641712000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 18568232000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -5415729000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 0.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 641712000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -650778000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -118019000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 152108000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Change In Payable: 1901367000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -302689000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 610207000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 292303000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Common Stock: 1694060000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -5415729000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 17776397000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 139296000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 14198485000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Current Assets: 27984186000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 121959000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 121959000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 15249461000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 3935198000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Defined Pension Benefit: 6105000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Depreciation: 591426000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 696796000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 696796000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 591426000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 169406034.00
GLAXO.NS income_statement (annual, 2024-03-31) — Diluted EPS: 34.83
GLAXO.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 5899610000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 185982000.00
GLAXO.NS income_statement (annual, 2024-03-31) — EBIT: 8179866000.00
GLAXO.NS income_statement (annual, 2024-03-31) — EBITDA: 8876662000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — End Cash Position: 641712000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -5614969000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 4129581000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 5507940000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -487762000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -8894000.00
GLAXO.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 486294000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 235538000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 2355119000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 5938615000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Gross Profit: 20219223000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Interest Expense: 17987000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 17987000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Interest Income: 678503000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 678503000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -17987000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 934323000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Inventory: 5250482000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 17776397000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: 87117000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Investment Properties: 9181000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 265000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 37003000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 64691000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 64691000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 2474645000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 4488582000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Net Income: 5899610000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 5899610000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 5899610000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Net Income Discontinuous Operations: 0.00
GLAXO.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 5899610000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 5899610000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 9598033000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 5899610000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Net Interest Income: 660516000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Net Investment Properties Purchase And Sale: 196873000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -1453764000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 660516000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -22790000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Net PPE: 3107318000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -70652000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 17540859000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 1463122000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 593274000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 9816160000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Normalized Income: 6578702620.19
GLAXO.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 5820155000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Operating Income: 8384856000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Operating Revenue: 34417708000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 169406034.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 20298000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 17727000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: -90053000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 235538000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -657303000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 6060000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 50778000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 2687260000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Other Payable: 1660176000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Other Properties: 174436000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 1278561000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 17926520000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Other Special Charges: -205767000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Payables: 11086044000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 426994000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Pretax Income: 8161879000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 5868000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -58022332000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -312215000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 1112834000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 14198485000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 696796000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 20052000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 20052000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 219048000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Restructuring And Mergern Acquisition: 1633027000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 8764352000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 56568568000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Sale Of Investment Properties: 196873000.00
GLAXO.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 241563000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 1797739000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 2284033000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Share Issued: 169406034.00
GLAXO.NS income_statement (annual, 2024-03-31) — Special Income Charges: -1427260000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 17776397000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 17540859000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -260405379.81
GLAXO.NS income_statement (annual, 2024-03-31) — Tax Provision: 2262269000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.28
GLAXO.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -2303763000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Total Assets: 35566175000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 17776397000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Total Debt: 186650000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 17776397000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Total Expenses: 26032852000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 17789778000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 7581989000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 2540317000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 2985789000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -939498000.00
GLAXO.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -939498000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 0.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Work In Process: 8067000.00
GLAXO.NS balance_sheet (annual, 2024-03-31) — Working Capital: 12734725000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 6304600000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 2683600000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 110000000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 147900000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 1694100000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 492600000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 21903900000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 1694100000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 16726900000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 209100000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 30143500000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 106100000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 106100000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 18131900000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 3986100000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 183400000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 2976400000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 5176200000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 16726900000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Investment Properties: 8500000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 110000000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 41800000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 41800000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 2559100000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 2976400000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 16543500000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 1502500000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 169406034.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 379800000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 588300000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 15032800000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 561800000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 2767300000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 21411300000.00
GLAXO.NS income_statement (quarterly, 2024-09-30) — Other Special Charges: -46900000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Payables: 11695500000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 169406034.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 16726900000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 16543500000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 37459900000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 16726900000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 147900000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 16726900000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 20733000000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 7316400000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 2601100000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 5390900000.00
GLAXO.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 12011600000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 3171400000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 9494200000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 169403095.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 13.57
GLAXO.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 3591600000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 188000000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 188000000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 169403095.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 13.57
GLAXO.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 2298800000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — EBIT: 3081900000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — EBITDA: 3269900000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 5902600000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 900000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 900000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Net Income: 2298800000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 2298800000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 2298800000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 2298800000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 2298800000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 2298800000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -900000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -900000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 3269900000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 2298800000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Operating Income: 2731200000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 9494200000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 350700000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 1736000000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 3081000000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 3591600000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 188000000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 782200000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.25
GLAXO.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 6763000000.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
GLAXO.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
GLAXO.NS income_statement (annual, 2025-03-31) — +Operating Expense: 11386509000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 3039600000.00
GLAXO.NS income_statement (annual, 2025-03-31) — +Total Revenue: 37260347000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 9743700000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 7082486000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 7082486000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 2925491000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2925491000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -2956177000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -2956177000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 26200000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 26200000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -158307000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -158307000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Amortization: 102221000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 102221000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 265000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 265000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 169406034.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 169375000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Basic EPS: 54.76
GLAXO.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 15.52
GLAXO.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 641712000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 1213656000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 1213656000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -247216000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 99512000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 99512000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 1694060000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1694060000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 5388477000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 5388477000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 24981036000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 24981036000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -7493759000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 4350000000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 4350000000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 1038477000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 1038477000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Change In Inventory: 433114000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: 590886000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 573425000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Change In Payable: 769688000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -728679000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 1848280000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 4746765000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Common Stock: 1694060000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 1694060000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -7493759000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 19513107000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 19513107000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 143199000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 143199000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 14730341000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 3519400000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Current Assets: 34098808000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 34098808000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 74592000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 74592000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 74592000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 74592000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 19051546000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 19051546000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 4063857000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 4063857000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Defined Pension Benefit: 0.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Defined Pension Benefit: 0.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Depreciation: 565704000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 667925000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 667925000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 147200000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 565704000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 147200000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 169406034.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 169375000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Diluted EPS: 54.76
GLAXO.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 15.52
GLAXO.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 9275829000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 2628700000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 225876000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 225876000.00
GLAXO.NS income_statement (annual, 2025-03-31) — EBIT: 12611921000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — EBIT: 3591500000.00
GLAXO.NS income_statement (annual, 2025-03-31) — EBITDA: 13279846000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — EBITDA: 3738700000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — End Cash Position: 5388477000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -7694202000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 3669680000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 3669680000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 12651758000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -696496000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 15127000.00
GLAXO.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 516828000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 133317000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 133317000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 3083798000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 3083798000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 5794764000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 5794764000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Gross Profit: 22530006000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 6224300000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Interest Expense: 13137000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 5800000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 13137000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 5800000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Interest Income: 713793000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 713793000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -13137000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 1182932000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Inventory: 4817368000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 4817368000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 19513107000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 19513107000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -458007000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 7833000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 7833000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 265000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 265000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 37003000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 37003000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 24920000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 24920000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 24920000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 24920000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: 0.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 1413152000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 1413152000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 4400906000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 4400906000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: 0.00
GLAXO.NS income_statement (annual, 2025-03-31) — Net Income: 9275829000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Net Income: 2628700000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 9275829000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 2628700000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 9275829000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 2628700000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 9275829000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 2628700000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 9275829000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 2628700000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 12551865000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 9275829000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 2628700000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Net Interest Income: 700656000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -5800000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -1444308000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 0.00
GLAXO.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: 700656000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -5800000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -6581000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Net PPE: 2838587000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 2838587000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -190050000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 19379790000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 19379790000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 1408661000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 1408661000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 1077930000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 1077930000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 604813000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 604813000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 12551558000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 3738700000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Normalized Income: 8739628446.78
GLAXO.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 2628700000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 12898974000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Operating Income: 11143497000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Operating Income: 3184700000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Operating Revenue: 37260347000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 9743700000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 169406034.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 169406034.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 2294000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 2294000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 715000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 715000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: -148755000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: -148755000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 133317000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 133317000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -694408000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 4280000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 4280000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 49006000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 406800000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 2724866000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1362700000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Other Payable: 2179508000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 2179508000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Other Properties: 2695400000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 2695400000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 682800000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 682800000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 19592559000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 19592559000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Other Special Charges: -31792000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Other Special Charges: 15108000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Payables: 14733043000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Payables: 14733043000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 100232000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 100232000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 428227000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 428227000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Pretax Income: 12598784000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 3585700000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 23759000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: 0.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -54400265000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -247216000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 1138268000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 1138268000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 14730341000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 3519400000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 667925000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 147200000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 19768000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 19768000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: 0.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 261592000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 261592000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Restructuring And Mergern Acquisition: 0.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 10586316000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 10586316000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 52955957000.00
GLAXO.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 57166000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 1875968000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 2392796000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Share Issued: 169406034.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 169406034.00
GLAXO.NS income_statement (annual, 2025-03-31) — Special Income Charges: 31792000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 19513107000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 19513107000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 19379790000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 19379790000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 192087446.78
GLAXO.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
GLAXO.NS income_statement (annual, 2025-03-31) — Tax Provision: 3322955000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 957000000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.26
GLAXO.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.27
GLAXO.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -817078000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Total Assets: 41080655000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 41080655000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 19513107000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 19513107000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Total Debt: 99512000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 99512000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 19513107000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 19513107000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Total Expenses: 26116850000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 6559000000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 21567548000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 21567548000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 6981847000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 6981847000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2516002000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2516002000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 5245173000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 5245173000.00
GLAXO.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 728288000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
GLAXO.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 728288000.00
GLAXO.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Work In Process: 9420000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 9420000.00
GLAXO.NS balance_sheet (annual, 2025-03-31) — Working Capital: 15047262000.00
GLAXO.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 15047262000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 2817800000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 8051700000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 169429752.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 12.10
GLAXO.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2877100000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 155200000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 155200000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 169429752.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 12.10
GLAXO.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 2050100000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — EBIT: 2794000000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — EBITDA: 2949200000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 5174600000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 4200000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 4200000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Net Income: 2050100000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 2050100000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 2050100000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 2050100000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 2050100000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 2050100000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -4200000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -4200000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 2949200000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 2050100000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Operating Income: 2356800000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 8051700000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 437200000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1136900000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 2789800000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2877100000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 155200000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 739700000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.27
GLAXO.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 5694900000.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
GLAXO.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
GLAXO.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 3264200000.00
GLAXO.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 10412600000.00
GLAXO.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 169409742.00
GLAXO.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 17.45
GLAXO.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 3638200000.00
GLAXO.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 203200000.00
GLAXO.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 203200000.00
GLAXO.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 169409742.00
GLAXO.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 17.45
GLAXO.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 2956200000.00
GLAXO.NS income_statement (quarterly, 2025-12-31) — EBIT: 4011200000.00
GLAXO.NS income_statement (quarterly, 2025-12-31) — EBITDA: 4214400000.00
GLAXO.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 6774400000.00
GLAXO.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 11900000.00